RIZZARI, CARMELO
RIZZARI, CARMELO
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Eight-year national multicenter experience on the use of glucarpidase as effective rescue therapy for delayed methotrexate elimination after high-dose methotrexate cycles administered in children with hemato-oncological diseases
2025 Peccatori, N; Coppola, M; Colombini, A; Silvestri, D; Bertorello, N; Kiren, V; Melchionda, F; Mura, R; Onofrillo, D; Gobbi, S; Mattera, R; Vinti, L; Casini, T; Santoro, N; Sperli, D; D'Ippolito, C; Conter, V; Biondi, A; Rizzari, C
Asparagine transport through SLC1A5/ASCT2 and SLC38A5/SNAT5 is essential for BCP‐ALL cell survival and a potential therapeutic target
2024 Taurino, G; Dander, E; Chiu, M; Pozzi, G; Maccari, C; Starace, R; Silvestri, D; Griffini, E; Bianchi, M; Carubbi, C; Andreoli, R; Mirandola, P; Valsecchi, M; Rizzari, C; D'Amico, G; Bussolati, O
Combined CAR-T/HSCT approach in a patient with refractory acute lymphoblastic leukemia and cystic fibrosis
2024 Di Majo, B; Vendemini, F; Bonanomi, S; Casartelli, P; Napolitano, S; Ottaviano, G; Prunotto, G; Verna, M; Sala, A; Migliorino, G; Petrella, F; Rosso, L; Claut, L; Rafaniello Raviele, P; Rizzari, C; Biondi, A; Balduzzi, A; Lucchini, G
Four Additional Doses of PEG-L-Asparaginase during the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study
2024 Conter, V; Valsecchi, M; Cario, G; Zimmermann, M; Attarbaschi, A; Stary, J; Niggli, F; Dalla Pozza, L; Elitzur, S; Silvestri, D; Locatelli, F; Moricke, A; Engstler, G; Smisek, P; Bodmer, N; Barbaric, D; Izraeli, S; Rizzari, C; Boos, J; Buldini, B; Zucchetti, M; Von Stackelberg, A; Matteo, C; Lehrnbecher, T; Lanvers-Kaminsky, C; Cazzaniga, G; Gruhn, B; Biondi, A; Schrappe, M
Prenatal origin of NUTM1 gene rearrangement in infant B-cell precursor acute lymphoblastic leukaemia
2024 Bardini, M; Fazio, G; Abascal, L; Meyer, C; Maglia, O; Sala, S; Palamini, S; Rebellato, S; Marschalek, R; Rizzari, C; Biondi, A; Cazzaniga, G
Hypersensitivity Reactions to Native E. coli L-asparaginase in Children with Acute Lymphoblastic Leukemia Treated in Trial ALL-BFM 2000: Impact of Treatment Schedule and Type of Glucocorticoid in Induction
2023 Moricke, A; Rizzari, C; Alten, J; Attarbaschi, A; Beier, R; Biondi, A; Burkhardt, B; Bodmer, N; Boos, J; Cario, G; Conter, V; Flotho, C; Kulozik, A; Lanvers-Kaminsky, C; Mann, G; Niggli, F; Silvestri, D; Von Stackelberg, A; Stanulla, M; Valsecchi, M; Schrappe, M; Zimmermann, M
Improved survival and MRD remission with blinatumomab vs. chemotherapy in children with first high-risk relapse B-ALL
2023 Locatelli, F; Zugmaier, G; Rizzari, C; Morris, J; Gruhn, B; Klingebiel, T; Parasole, R; Linderkamp, C; Flotho, C; Petit, A; Micalizzi, C; Zeng, Y; Desai, R; Kormany, W; Eckert, C; Moricke, A; Sartor, M; Hrusak, O; Peters, C; Saha, V; Vinti, L; von Stackelberg, A
Incidence and Characteristics of Hypersensitivity Reactions to PEG-asparaginase Observed in 6136 Children with Acute Lymphoblastic Leukemia Enrolled in the AIEOP-BFM ALL 2009 Study Protocol
2023 Rizzari, C; Möricke, A; Valsecchi, M; Conter, V; Zimmermann, M; Silvestri, D; Attarbaschi, A; Niggli, F; Barbaric, D; Stary, J; Elitzur, S; Cario, G; Vinti, L; Boos, J; Zucchetti, M; Lanvers-Kaminsky, C; Von Stackelberg, A; Biondi, A; Schrappe, M
Blinatumomab in Children and Adolescents with Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia: A Real-Life Multicenter Retrospective Study in Seven AIEOP (Associazione Italiana di Ematologia e Oncologia Pediatrica) Centers
2022 Beneduce, G; De Matteo, A; Stellato, P; Testi, A; Bertorello, N; Colombini, A; Putti, M; Rizzari, C; Cesaro, S; Cellini, M; Barisone, E; Petruzziello, F; Menna, G; Parasole, R
Challenging Management of Severe Differentiation Syndrome in Pediatric Acute Promyelocytic Leukemia Treated with ATRA/ATO
2022 Molinaro, A; Zanta, D; Moleti, M; Giona, F; Conter, V; Rizzari, C; Biondi, A; Testi, A
Daratumumab with or without chemotherapy in relapsed and refractory acute lymphoblastic leukemia. A retrospective observational Campus ALL study
2022 Cerrano, M; Bonifacio, M; Olivi, M; Curti, A; Malagola, M; Dargenio, M; Scattolin, A; Papayannidis, C; Forghieri, F; Gurrieri, C; Tanasi, I; Zappasodi, P; Starza, R; Fracchiolla, N; Chiusolo, P; Giaccone, L; Del Principe, M; Giglio, F; Defina, M; Favre, C; Rizzari, C; Castella, B; Pizzolo, G; Ferrara, F; Chiaretti, S; Foa, R
FLT3-ITD in Children with Early T-cell Precursor (ETP) Acute Lymphoblastic Leukemia: Incidence and Potential Target for Monitoring Minimal Residual Disease (MRD)
2022 Locatelli, F; Lo Nigro, L; Andriano, N; Buldini, B; Silvestri, D; Villa, T; Parasole, R; Barisone, E; Testi, A; Biondi, A; Valsecchi, M; Rizzari, C; Conter, V; Basso, G; Cazzaniga, G
Global effort to evacuate Ukrainian children with cancer and blood disorders who have been affected by war
2022 Agulnik, A; Kizyma, R; Salek, M; Wlodarski, M; Pogorelyy, M; Oszer, A; Yakimkova, T; Nogovitsyna, Y; Dutkiewicz, M; Dalle, J; Dirksen, U; Eggert, A; Fernandez-Teijeiro, A; Greiner, J; Kraal, K; Mueller, A; Sramkova, L; Zecca, M; Wise, P; Mlynarski, W; Avula, M; Adyrov, M; Berlanga, P; Blackwood, C; Bouffet, E; Czauderna, P; de Koning, L; dos Reis Farinha, N; Foster, W; Graetz, D; Gupta, S; Holter, W; Hough, R; Kliuchkivska, K; Kolenova, A; Kolodrubiec, J; Moreira, D; Mukkada, S; Mykychak, I; Raciborska, A; Salman, Z; Sopilnyak, A; Tyupa, S; Vinitsky, A; Wobst, N; Miller, B; Rasul, S; Rodriguez-Galindo, C; Alanbousi, I; Alexander, S; Apel, A; Bal, W; Balwierz, W; Basset-Salom, L; Bastardo Blanco, D; Bauer, K; Bayazitov, I; Bhakta, N; Bien, E; Bieniek, K; Blair, S; Bodak, K; Bordeianu, I; Braganca, J; Bucurenci, M; Budny, E; Budzyn, A; Bumgardner, C; Burditt, R; Burnside Clapp, V; Bykov, V; Canete, A; Carnelli, M; Cela, E; Cepowska, Z; Chaber, R; Cherner-Drieux, A; Chubata, M; Clough, H; Czernicka - Siwecka, J; Czyzewski, K; Dashchakovska, O; Dembowska-Baginska, B; Derwich, K; Dommett, R; Dorosh, O; Drabko, K; Dragomir, M; Dworzak, M; Dyma, S; Earl, J; English, M; Evseev, D; Farren, B; Fedyk, N; Ferneza, S; Fox Irwin, L; Galazkowski, R; Ganieva, G; Garanzha, V; Gelman, M; Godzinski, J; Goeres, A; Golban, R; Griksaitis, M; Hampel, M; Hastings, S; Heenen, D; Hill, M; Holiuk, I; Hutnik, L; Irga-Jaworska, N; Istomin, O; Janczar, S; Kacharian, A; Kalwak, K; Karolczyk, G; Karpenko, N; Katsubo, H; Kaznowska, B; Kentsis, A; Ketteler, P; Kienesberger, A; Kiselev, R; Kizyma, Z; Klymniuk, H; Kostiuk, Y; Kowalik, T; Kozlova, O; Kozubenko, V; Kramar, T; Krawczuk-Rybak, M; Kulemzina, I; Kurkowska, P; Kuzyk, A; Ladenstein, R; Laguna, P; Lassaletta, A; Lehmberg, K; Leontieva, O; Liashenko, S; Loizou, L; Lucchetta, S; Lupo, M; Lysytsia, L; Lysytsia, O; Machnik, K; Mainland, J; Matczak, K; Matysiak, M; Mayeur, P; Minervina, A; Mishkova, V; Mizia-Malarz, A; Morales La Madrid, A; Moreno, L; Moskvin, V; Muszynska-Roslan, K; Nelson, A; Ociepa, T; Oltolini, S; Onipko, N; Pappas, A; Patel, A; Patrahau, A; Pauley, J; Pavlenko, Y; Pavlovych, A; Peregud-Pogorzelski, J; Perek-Polnik, M; Perez, V; Perez-Martinez, A; Pikman, Y; Pitozzi, G; Portugal, R; Posternak, V; Prete, A; Pritchard-Jones, K; Radaelli, A; Reeves, T; Reinhardt, D; Reshetnyak, A; Rider, A; Rizzari, C; Rizzi, D; Rodriguez Hermosillo, K; Ronenko, O; Rostowska, A; Rudko, L; Sakaan, F; Sakhar, N; Savva, N; Scaccaglia, D; Schaeffer, E; Schneider, C; Scobie, N; Semeniuk, O; Shevchyk, R; Shuler, A; Shvets, S; Skoczen, S; Smeal, W; Sokolowski, I; Sonkin, A; Stepanjuk, A; Spota, A; Sterba, J; Styczynski, J; Svintsova, O; Synyuta, A; Szczepanski, T; Szczucinski, P; Szmyd, B; Tasso Cereceda, M; Teliuk, A; Tomanek, I; Topping, P; Torrent, M; Trelinska, J; Troyanovska, O; Trubnikova, E; Tsurkan, L; Tsymbalyuk-Voloshyn, I; Urasinski, T; Urbanek-Dadela, A; Vasilieva, N; Vasilyeva, A; Verdu-Amoros, J; Vilcu-Bajurean, N; Vinitsky, L; Volpe, G; Vorobel, O; Wachowiak, J; Wasiak, M; Wiedower, L; Wuenschel, L; Wysocki, M; Yurieva, M; Zagurska, A; Zakharenko, S; Zakharenko, A; Zapotochna, K; Zawitkowska, J
Impact of Antibodies Against Polyethylene Glycol on the Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukaemia: A Population Pharmacokinetic Approach
2022 Siebel, C; Lanvers-Kaminsky, C; Alten, J; Smisek, P; Nath, C; Rizzari, C; Boos, J; Wurthwein, G
Inotuzumab ozogamicin as single agent in pediatric patients with relapsed and refractory acute lymphoblastic leukemia: results from a phase II trial
2022 Pennesi, E; Michels, N; Brivio, E; van der Velden, V; Jiang, Y; Thano, A; Ammerlaan, A; Boer, J; Beverloo, H; Sleight, B; Chen, Y; Vormoor-Burger, B; Rives, S; Bielorai, B; Rossig, C; Petit, A; Rizzari, C; Engstler, G; Stary, J; Bautista Sirvent, F; Chen-Santel, C; Bruno, B; Bertrand, Y; Rialland, F; Plat, G; Reinhardt, D; Vinti, L; Von Stackelberg, A; Locatelli, F; Zwaan, C
Mucopolysaccharidosis-Plus Syndrome, a Rapidly Progressive Disease: Favorable Impact of a Very Prolonged Steroid Treatment on the Clinical Course in a Child
2022 Faraguna, M; Musto, F; Crescitelli, V; Iascone, M; Spaccini, L; Tonduti, D; Fedeli, T; Kullmann, G; Canonico, F; Cattoni, A; Dell'Acqua, F; Rizzari, C; Gasperini, S
NUP214–ABL1 fusion in childhood T-ALL
2022 Veltri, G; Sandei, M; Silvestri, D; Bresolin, S; Pession, A; Santoro, N; Ziino, O; Veltroni, M; Rizzari, C; Biffi, A; Valsecchi, M; Conter, V; Buldini, B; Accordi, B; Serafin, V
Osteonecrosis in paediatric acute lymphoblastic leukaemia: Incidence, risk factors, radiological patterns and evolution in a single-centre cohort
2022 Brivio, E; Cossio, A; Borra, D; Silvestri, D; Prunotto, G; Colombini, A; Verna, M; Rizzari, C; Biondi, A; Conter, V; Valsecchi, M; Balduzzi, A
PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120
2022 Fazio, G; Bresolin, S; Silvestri, D; Quadri, M; Saitta, C; Vendramini, E; Buldini, B; Palmi, C; Bardini, M; Grioni, A; Rigamonti, S; Galbiati, M; Mecca, S; Savino, A; Peloso, A; Tu, J; Bhatia, S; Borkhardt, A; Micalizzi, C; Lo Nigro, L; Locatelli, F; Conter, V; Rizzari, C; Valsecchi, M; Te Kronnie, G; Biondi, A; Cazzaniga, G
Pharmacological and clinical monitoring in children with acute lymphoblastic leukemia treated with a biogeneric PEG-l-asparaginase product
2022 Matteo, C; Colombini, A; Bettini, L; Porcu, L; Barzaghi, S; Ceruti, T; Silvestri, D; Amoroso, A; Dell'Acqua, F; Gotti, G; Nastasi, C; Zucchetti, M; Rizzari, C